- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06455202
Uno studio di fase 3 su Barzolvolimab in partecipanti con orticaria cronica spontanea (CSU) (EMBARQ-CSU2)
Uno studio di fase 3 randomizzato, in doppio cieco, controllato con placebo per valutare l'efficacia e la sicurezza di barzolvolimab in pazienti con orticaria cronica spontanea che rimangono sintomatici nonostante il trattamento con antistaminico H1 (EMBARQ-CSU2)
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This is a global, multicenter, randomized, double-blind, parallel group, placebo-controlled phase 3 study investigating the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) who are symptomatic despite treatment with non-sedating second generation H1-antihistamines at 1-4 times the locally approved dose.
There is a screening period of up to 4 weeks, followed by a 24-week placebo-controlled treatment period, a 28-week active treatment period where all participants receive barzolvolimab followed by a 16-week treatment free period.
Approximately 915 adult participants (610 in the active arms and 305 in the placebo arm) will be randomly assigned to the treatment arms.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
New South Wales
-
Charlestown, New South Wales, Australia, 2290
- Novatrials
-
Darlinghurst, New South Wales, Australia, 2010
- Skin and Cancer Foundation - The Skin Hospital
-
Kogarah, New South Wales, Australia, 2217
- St George Dermatology and Skin Cancer Center
-
Westmead, New South Wales, Australia, 2145
- Westmead Hospital
-
-
Queensland
-
Brisbane, Queensland, Australia, 4102
- Princess Alexandra Hospital
-
Coorparoo, Queensland, Australia, 4151
- Cornerstone Dermatology
-
Woolloongabba, Queensland, Australia, 4102
- Veracity Clinical Research Pty Ltd
-
-
Victoria
-
Box Hill, Victoria, Australia, 3128
- Box Hill Hospital
-
East Melbourne, Victoria, Australia, 3002
- Dr Rodney Sinclair Pty Ltd
-
Melbourne, Victoria, Australia, 3004
- The Alfred Hospital
-
Parkville, Victoria, Australia, 3050
- The Royal Melbourne Hospital
-
-
-
-
-
Dupnitsa, Bulgaria, 2600
- Medical Centre Asklepii OOD
-
Haskovo, Bulgaria, 6300
- Medical Center - Pulmo 2018
-
Lovech, Bulgaria, 5500
- Medical Center Medconsult Pleven
-
Pazardzhik, Bulgaria, 4400
- Multiprofile Hospital for Active Treatment - Pazardzhik AD
-
Plovdiv, Bulgaria, 4002
- University Multiprofile Hospital for Active Treatment Sveti Georgi EAD
-
Rousse, Bulgaria, 7000
- Medical Center Prolet
-
Sevlievo, Bulgaria, 5400
- Medical Center Unimed EOOD
-
Sofia, Bulgaria, 1431
- University Multiprofile Hospital for Active Treatment Aleksandrovska EAD
-
Sofia, Bulgaria, 1527
- University Multiprofile Hospital for Active Treatment "Tsaritsa Yoanna - ISUL"
-
Sofia, Bulgaria, 1431
- Diagnostic and Consultative Center Aleksandrovska EOOD
-
Sofia, Bulgaria, 1680
- Diagnostic-Consultative Centre Convex EOOD
-
Sofia, Bulgaria, 1202
- Diagnostic-consultative center Ascendent EOOD
-
-
-
-
-
Kingston, Canada, K7L 2V7
- Kingston Health Science Center
-
Québec, Canada, G1W4R4
- Centre de Recherche Saint-Louis (Québec)
-
-
Alberta
-
Edmonton, Alberta, Canada, T5J 3S9
- Laser Rejuvenation Clinics Edmonton D.T. Inc.
-
Edmonton, Alberta, Canada, T6H 4J8
- Vida Clinical Research
-
Edmonton, Alberta, Canada, T6W 0J5
- Rejuvenation Dermatology Edmonton South
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 3C3
- LEADER research
-
London, Ontario, Canada, N6H 5L5
- DermEffects
-
North Bay, Ontario, Canada, P1B 3Z7
- North Bay Dermatology Centre
-
Ottawa, Ontario, Canada, K1H1E4
- Ottawa Allergy Research Corporation
-
Richmond Hill, Ontario, Canada, L4B 1L1
- York Dermatology Clinic & Research Centre
-
Toronto, Ontario, Canada, M2N 3A6
- North York Research Inc.
-
Windsor, Ontario, Canada, N8X 2G1
- Joel Liem Medicine Professional Corporation
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7T0G3
- Saskatoon Dermatology Centre
-
-
-
-
-
Lo Barnechea, Chile, 7691236
- Clinica MEDS La Dehesa
-
Osorno, Chile, 5290000
- Hospital Base San Jose de Osorno
-
Providencia, Chile, 7500000
- Enroll SpA - Dr. Manuel Barros Borgono
-
Recoleta, Chile, 8420000
- Clinica Davila - Recoleta
-
Recoleta, Chile, 8420383
- Centro Internacional de Estudios Clinicos (CIEC)
-
Santiago, Chile, 8350595
- BIOCINETIC Ltda
-
Vitacura, Chile, 7630000
- Dermacross Clinica Dermatologica
-
Viña del Mar, Chile, 2520000
- Medical Skin Center
-
-
-
-
-
Barranquilla, Colombia, 8001
- Centro Integral de Reumatologia Del Caribe
-
Medellín, Colombia, 50012
- Centro de Inmunología y Genética - CIGE S.A.S
-
Medellín, Colombia, 50015
- Hospital General de Medellín Luz Castro de Gutiérrez
-
Medellín, Colombia, 50021
- Fundación Centro de Investigation Clínica CIC
-
Medellín, Colombia, 50010
- Hospital Alma Mater de Antioquia
-
Soledad, Colombia, 83001
- Fundación Hospital Universidad del Norte
-
-
-
-
-
Rijeka, Croazia, 51000
- Special Hospital Medico
-
Zagreb, Croazia, 10000
- Solmed Clinic
-
-
-
-
-
Tbilisi, Georgia, 0119
- LTD" Healthy Future"
-
Tbilisi, Georgia, 0159
- LTD "Center of Allergy and Immunology"
-
Tbilisi, Georgia, 0179
- David Abuladze Georgian Italian Clinic
-
Tbilisi, Georgia, 0186
- LTD "Multiprofile Clinic Consilium Medulla"
-
-
-
-
-
Aachen, Germania, 52074
- Universitätsklinikum der RWTH Aachen Hautklinik
-
Bad Bentheim, Germania, 48455
- Fachklinik Bad Bentheim
-
Berlin, Germania, 10629
- Emovis GmbH
-
Bonn, Germania, 53127
- Universitätsklinikum Bonn
-
Dresden, Germania, 01307
- Universitätsklinikum Carl Gustav Carus an der TU Dresden
-
Düsseldorf, Germania, 40225
- Universitätsklinikum Düsseldorf
-
Essen, Germania, 45147
- Universitätsklinikum Essen
-
Hamburg, Germania, 20095
- Eurofins bioskin Research Center Dermalology
-
Lübeck, Germania, 23538
- UKSH Lübeck, Institut für Entzündungsmedizin
-
Mannheim, Germania, 68167
- Universitätsklinikum Mannheim
-
Münster, Germania, 48149
- Universitätsklinikum Münster
-
Remscheid, Germania, 42897
- Hautarztpraxis Dariusch Mortazawi
-
Tübingen, Germania, 72076
- Universitäts-Hautklinik, Studienzentrum Immundermatologie
-
-
-
-
-
Ahmedabad, India, 380005
- Panchshil Hospital - Ahmedabad
-
Ahmedabad, India, 380016
- B. J. Medical College and Civil Hospital
-
Belagavi, India, 590010
- KLES Dr Prabhakar Kore Hospital & Medical Research Centre
-
Bhubaneswar, India, 751019
- All India Institute of Medical Sciences
-
Jaipur, India, 302017
- Apex Hospitals Pvt Ltd
-
Mysore, India, 570001
- K R Hospital
-
Pune, India, 411004
- Deenanath Mangeshkar Hospital and Research Centre
-
Vadodara, India, 391760
- Sumandeep Vidyapeeth University - Dhiraj Hospital
-
-
Gujarat
-
Surat, Gujarat, India, 395002
- Nirmal Hospital PVT LTD
-
Vadodara, Gujarat, India, 390001
- Medical College Baroda & SSG Hospital
-
-
Maharashtra
-
Nagpur, Maharashtra, India, 440009
- Shree Hospital & Critical Care Centre
-
Nashik, Maharashtra, India, 422101
- Assured Care Plus Hospital
-
Pune, Maharashtra, India, 411005
- Oyster & Pearl Hospitals
-
-
Rajasthan
-
Jaipur, Rajasthan, India, 302012
- Excelcare Hospital
-
-
Uttar Pradesh
-
Kanpur, Uttar Pradesh, India, 208002
- G.S.V.M. Medical College - Kanpur
-
-
-
-
-
Genova, Italia, 16132
- IRCCS Ospedale Policlinico San Martino
-
Milan, Italia, 20157
- Asst Fbf Sacco
-
Padova, Italia, 38068
- Azienda Ospedale Università di Padova
-
Rozzano, Italia, 20089
- Humanitas Research Hospital
-
Salerno, Italia, 84131
- AOU San Giovanni di Dio e Ruggi d'Aragona
-
San Donato Milanese, Italia, 20097
- IRCCS Policlinico San Donato
-
Torino, Italia, 10126
- Ospedale San Lazzaro PO Molinette
-
-
-
-
-
Kaunas, Lituania, LT-44192
- CD8 Klinika
-
Kaunas, Lituania, LT-49387
- UAB Ausros Medicinos Centras
-
Vilnius, Lituania, LT-08109
- UAB "Alerginių susirgimų diagnostikos ir gydymo centras"
-
Vilnius, Lituania, LT-08406
- Santaros KTC (klinikiniu tyrimu centras)
-
-
-
-
-
Chihuahua City, Messico, 31200
- Unidad de Investigación Cima S.a
-
Chihuahua City, Messico, 31203
- Meidadvance Clinical
-
Cuauhtémoc, Messico, 06100
- Cryptex
-
Guadalajara, Messico, 44130
- Centro de Investigación Medico Biologica
-
Guadalajara, Messico, 44340
- CIMET
-
Guadalajara, Messico, 44670
- Panamerican Guadalajara
-
Monterrey, Messico, 64718
- Eukarya Pharmasite
-
Morelia, Messico, 58249
- CECYPE
-
Mérida, Messico, 97000
- Centro de Desarrollo Biomédico
-
Mérida, Messico, 97125
- Mérida Investigación Clínica
-
San Juan del Río, Messico, 76800
- Unidad de Medicina Especializada
-
Veracruz, Messico, 91900
- FAICIC
-
-
-
-
-
Auckland, Nuova Zelanda, 1010
- Optimal Clinical Trials - Central
-
Christchurch, Nuova Zelanda, 8013
- Pcrn Chch
-
Dunedin, Nuova Zelanda, 9016
- Momentum Clinical Research Dunedin
-
Hamilton, Nuova Zelanda, 3200
- Lakeland Clinical Trials - Waikato
-
Nelson, Nuova Zelanda, 7011
- velocity Nova Sp. z o.o.
-
Rotorua, Nuova Zelanda, 3010
- Pacific Clinical Research Network Rotorua
-
Tauranga, Nuova Zelanda, 3110
- Momentum Clinical Research Tauranga
-
Upper Hutt, Nuova Zelanda, 5018
- Lakeland Clinical Trials Wellington
-
-
-
-
-
Amsterdam, Olanda, 1105 AZ
- AmdsterdamUMC locatie AMC
-
Roosendaal, Olanda, 4708 AE
- Bravis Hospital
-
Utrecht, Olanda, 3584 CX
- University Medical Center Utrecht
-
-
-
-
-
Częstochowa, Polonia, 42-217
- Centrum Medyczne Pratia Częstochowa
-
Częstochowa, Polonia, 42-202
- Klinika Dermatologii i Dermatologii Onkologicznej
-
Elblag, Polonia, 82-300
- Centrum Kliniczno-Badawcze J.Brzezicki,B.Górnikiewicz-Brzezicka, Lekarze Spółka Partnerska
-
Gdansk, Polonia, 80-382
- Synexus Polska Sp. z o.o.
-
Grodzisk Mazowiecki, Polonia, 05-825
- Mazowieckie Centrum Badań Klinicznych SC IWONA CZAJKOWSKA ANNA PODRAZKA-SZCZEAPANIAK
-
Katowice, Polonia, 40-611
- Provita Sp zoo
-
Krakow, Polonia, 30-363
- Centrum Medyczne Plejady
-
Krakow, Polonia, 31-624
- Malopolskie Centrum Alergologii
-
Krakow, Polonia, 30-033
- Centrum Medyczne "All-Med" Badania Kliniczne
-
Lodz, Polonia, 92-213
- Uniwersytet Medyczny w Łodzi - Centrum Wsparcia Badań Klinicznych
-
Lublin, Polonia, 20-362
- Velocity Nova Sp. z o.o.
-
Lublin, Polonia, 20-607
- DERMEDIC Iwona Zdybska
-
Lublin, Polonia, 20-412
- Pro Life Medica ETG Lublin
-
Lublin, Polonia, 20-753
- LUXDERM Specjalistyczny Gabinet Dermatologiczny Prof. dr hab. n. med. Dorota Krasowska
-
Nowa Sól, Polonia, 67-100
- Twoja Przychodnia Nowosolskie Centrum Medyczne
-
Opole, Polonia, 45-401
- Uniwersytecki Szpital Kliniczny w Opolu
-
Oświęcim, Polonia, 32-600
- Medicome Sp. Z O.O.
-
Poznan, Polonia, 60-214
- Centrum Alergologii Teresa Hofman Sp. z.o.o.
-
Poznan, Polonia, 60-309
- EMC Instytut Medyczny SA, PL Certus Szpital i Ambulatorium
-
Poznan, Polonia, 60-693
- Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej Alergologia Plus Osrodek Diagnostyki I Terapii Uczulen
-
Rzeszów, Polonia, 35-055
- Uniwersytecki Szpital Kliniczny im. Fryderka Chopina w Rzeszowie Klinika Dermatologii i Dermatologii Onkologicznej
-
Rzeszów, Polonia, 35-205
- EMED Centrum Usług Medycznych Ewa Śmiałek
-
Tarnów, Polonia, 33-100
- ALERGO-MED SPECJALISTYCZNA PRZYCHODNIA LEKARSKA Spolka. z o. o.
-
Warsaw, Polonia, 02-677
- ETG Warszawa
-
Warsaw, Polonia, 02-672
- Synexus Polska Sp. z o.o.
-
Warsaw, Polonia, 00-874
- Medicover Integrated Clinical Services Sp. z o.o. Centrum Medyczne Warszawa
-
-
-
-
-
Bristol, Regno Unito, BS10 5NB
- Southmead Hospital
-
Cambridge, Regno Unito, CB2 0QQ
- Cambridge University Hospitals, Addenbrooke's Hospital
-
Edinburgh, Regno Unito, EH4 2XU
- Western General Hospital
-
Glasgow, Regno Unito, G51 4TF
- Queen Elizabeth University Hospital
-
High Wycombe, Regno Unito, HP11 2QW
- Velocity Clinical Research High Wycombe
-
Leeds, Regno Unito, LS9 7TF
- St James's University Hospital
-
London, Regno Unito, E1 1FR
- The Royal London Hospital
-
North Finchley, Regno Unito, N12 8BU
- Velocity Clinical Research, North London - PPDS
-
Oxford, Regno Unito, OX44 9PU
- Virtual Clinical Trials Centre, The Stables
-
Plymouth, Regno Unito, PL6 5FP
- University Hospitals Plymouth NHS Trust
-
Reading, Regno Unito, RG1 5AN
- Royal Berkshire Hospital
-
Romford, Regno Unito, RM1 3PJ
- Velocity Clinical Research - Romford
-
Wakefield, Regno Unito, WF1 4DG
- Pinderfields Hospital
-
-
-
-
-
Bardejov, Slovacchia, 08501
- MAXDERM s.r.o.
-
Bratislava, Slovacchia, 85101
- Derma therapy spol. s.r.o.
-
Košice, Slovacchia, 04022
- ALERSA, sro
-
Trnava, Slovacchia, 91702
- Fakultna nemocnica Trnava
-
-
-
-
-
Barcelona, Spagna, 08003
- Hospital del Mar
-
Cadiz, Spagna, 11009
- Hospital Universitari Puerta del Mar
-
Madrid, Spagna, 28006
- Hospital Universitario de La Princesa
-
Madrid, Spagna, 28041
- Hospital 12 De Octubre
-
Pamplona, Spagna, 31008
- Clinica Universidad Navarra- Pamplona
-
Pozuelo de Alarcón, Spagna, 28223
- Hospital Quironsalud Madrid
-
Seville, Spagna, 41012
- FutureMeds Sevilla
-
Seville, Spagna, 41009
- Hospital universitario Virgen Macarena
-
Torrejón de Ardoz, Spagna, 28850
- Hospital Universitario de Torrejón
-
Valencia, Spagna, 46026
- Hospital Universitari i Politecnic La Fe de Valencia
-
Valencia, Spagna, 46940
- Hospital de Manises
-
-
-
-
Alabama
-
Cullman, Alabama, Stati Uniti, 35058
- Allervie Clinical Research - Cullman
-
-
Arizona
-
Litchfield Park, Arizona, Stati Uniti, 85340
- Research Solutions of Arizona PC
-
Scottsdale, Arizona, Stati Uniti, 85258
- Medical Research of Arizona a division of Allergy, Asthma, & Immunology, Assoc. Ltd.
-
Scottsdale, Arizona, Stati Uniti, 85260
- Center for Dermatology & Plastic Surgery
-
-
California
-
Bakersfield, California, Stati Uniti, 93301
- Kern Research, Inc.
-
Los Angeles, California, Stati Uniti, 90057
- LA Universal Research Center, Inc.
-
Los Angeles, California, Stati Uniti, 90025
- California Allergy and Asthma Medical Group
-
Los Angeles, California, Stati Uniti, 90024
- UCLA Clinical Trials Contracts & Strategic Relations
-
Mission Viejo, California, Stati Uniti, 92691
- Allergy and Asthma Associates of Southern Cal
-
Pasadena, California, Stati Uniti, 91107
- Huntington Asthma & Allergy Center
-
San Diego, California, Stati Uniti, 92123
- University Clinical Trials
-
San Diego, California, Stati Uniti, 92120
- WR-MCCR
-
San Diego, California, Stati Uniti, 92120
- Apex Clinical Research
-
Santa Monica, California, Stati Uniti, 90404
- Clinical Science Institute
-
Santa Monica, California, Stati Uniti, 90404
- Raffi Tachdjian MD, Inc
-
-
Colorado
-
Castle Rock, Colorado, Stati Uniti, 80109
- Clarity Dermatology, PLLC
-
Colorado Springs, Colorado, Stati Uniti, 80907
- Asthma and Allergy Associates
-
-
Florida
-
Coral Gables, Florida, Stati Uniti, 33134
- Driven Research LLC
-
Delray Beach, Florida, Stati Uniti, 33484
- Palm Beach Dermatology Group
-
Doral, Florida, Stati Uniti, 33172
- Dolphin Medical Research
-
Miami, Florida, Stati Uniti, 33165
- South FL Clinical Research LLC
-
Miami, Florida, Stati Uniti, 33173
- Dade Florida Clinical Research Center
-
Miami Lakes, Florida, Stati Uniti, 33014
- Deluxe Health Center
-
Orlando, Florida, Stati Uniti, 32807
- Revival Clinical Research
-
Sanford, Florida, Stati Uniti, 32771
- International Clinical Research - FL LLC
-
Tamarac, Florida, Stati Uniti, 33321
- D&H Tamarac Research Center, LLC
-
Tampa, Florida, Stati Uniti, 33613
- University of South Florida
-
Tampa, Florida, Stati Uniti, 33615
- Olympian Clinical Research
-
Tampa, Florida, Stati Uniti, 33609
- MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research
-
Tampa, Florida, Stati Uniti, 33607
- Advanced Clinical Research Institute (ACRI) - Florida
-
Tampa, Florida, Stati Uniti, 33607
- Deluxe Health Center
-
-
Georgia
-
Columbus, Georgia, Stati Uniti, 31904
- Lane Dermatology Research - Centricity - PPDS
-
Macon, Georgia, Stati Uniti, 31217
- Skin Care Physicians of Georgia
-
-
Idaho
-
Boise, Idaho, Stati Uniti, 83706
- Treasure Valley Medical Research
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60612
- Rush University Medical Center
-
Normal, Illinois, Stati Uniti, 61761
- Sneeze Wheeze and Itch Associates LLC
-
-
Indiana
-
Plainfield, Indiana, Stati Uniti, 46168
- The Indiana Clinical Trials Center, PC
-
South Bend, Indiana, Stati Uniti, 46617
- South Bend Clinic
-
-
Kansas
-
Kansas City, Kansas, Stati Uniti, 66160-8500
- University of Kansas Medical Center
-
-
Kentucky
-
Bowling Green, Kentucky, Stati Uniti, 42104
- Equity Medical
-
Lexington, Kentucky, Stati Uniti, 40509
- Allergy & Asthma Associates
-
-
Louisiana
-
Baton Rouge, Louisiana, Stati Uniti, 70808
- Velocity Clinical Research - The Dermatology Clinic - Baton Rouge - PPDS
-
-
Maryland
-
Towson, Maryland, Stati Uniti, 21204
- Continental Clinical Research Solutions, LLC - ClinEdge - PPDS
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Brigham and Women's Hospital
-
-
Michigan
-
Caledonia, Michigan, Stati Uniti, 49316
- Derm Institute of Western Michigan
-
Clarkston, Michigan, Stati Uniti, 48346
- Clarkston Skin Research - Clarkston
-
-
Missouri
-
St Louis, Missouri, Stati Uniti, 63141
- Washington University School of Medicine
-
St Louis, Missouri, Stati Uniti, 63141
- Midwest Clinical Research, LLC
-
-
Nebraska
-
Omaha, Nebraska, Stati Uniti, 68144
- Skin Specialists PC
-
-
New Jersey
-
Belleville, New Jersey, Stati Uniti, 07109
- Hudson-Essex Allergy
-
Paramus, New Jersey, Stati Uniti, 07652
- Impact Medical / Circuit Clinical
-
Riverdale, New Jersey, Stati Uniti, 07457
- Impact Medical / Circuit Clinical
-
-
New York
-
New York, New York, Stati Uniti, 10128
- OptiSkin Medical
-
New York, New York, Stati Uniti, 10023
- Equity Medical LLC
-
-
Ohio
-
Boardman, Ohio, Stati Uniti, 44512
- Optima Research
-
Columbus, Ohio, Stati Uniti, 43235
- Optimed Research Ltd - ClinEdge - PPDS
-
-
Pennsylvania
-
Hershey, Pennsylvania, Stati Uniti, 17033
- Penn State Health Milton Hershey Med Cen
-
-
Rhode Island
-
Johnston, Rhode Island, Stati Uniti, 02919
- Clinical Partners LLC
-
-
Texas
-
El Paso, Texas, Stati Uniti, 79932
- Western Sky Medical Research
-
Pflugerville, Texas, Stati Uniti, 78660
- Austin Institute for Clinical Research, Inc.
-
San Antonio, Texas, Stati Uniti, 78213
- Rainey & Finklea San Antonio Dermatology
-
-
Utah
-
Murray, Utah, Stati Uniti, 84107
- Allergy Associates of Utah - Sandy
-
West Valley City, Utah, Stati Uniti, 84120
- Kalo Clinical Research
-
-
-
-
-
Bangkok Noi, Tailandia, 10700
- Siriraj Hospital
-
Chiang Mai, Tailandia, 50200
- Maharaj Nakorn Chiang Mai Hospital
-
Khlong Luang, Tailandia, 12120
- Thammasat University Hospital
-
Khon Kaen, Tailandia, 40002
- Khon Kaen University
-
-
-
-
-
Sfax, Tunisia, 3029
- Hôpital Hédi Chaker
-
Tunis, Tunisia, 1007
- La Rabta Hospital
-
Tunis, Tunisia, 1008
- Habib Thameur Hospital
-
-
-
-
-
Debrecen, Ungheria, 4032
- Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
-
Szeged, Ungheria, 6725
- Szent-Gyorgyi Albert Klinikai Kozpont
-
Szolnok, Ungheria, 5000
- Allergo-Derm Bakos Kft.
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Key Inclusion Criteria:
-
Males and females, >/= 18 years of age.
-
Chronic spontaneous urticaria (CSU) >/= 6 months prior to Screening (Visit 1).
-
CSU despite the use of a stable regimen of second generation non-sedating H1-antihistamine as defined by:
- The presence of hives for >/= 6 weeks at any time prior to Visit 1 despite the use of non-sedating H1-antihistamines.
- Must be on a stable regimen of second generation non-sedating H1-antihistamine for >/= 4 weeks prior to study treatment.
- UAS7 of >/= 16 and ISS7 of >/= 8 during the 7 days prior to study treatment.
-
Normal blood counts and liver function tests.
-
Both males and females of child-bearing potential must agree to use highly effective contraceptives during the study and for 150 days after treatment.
-
Willing and able to complete a daily symptom electronic diary and comply with study visits.
-
Participants with and without prior biologic experience are eligible.
Key Exclusion Criteria:
- Women who are pregnant or nursing.
- Chronic urticaria whose predominant manifestation is due to CIndU.
- Other diseases associated with urticaria.
- Active pruritic skin condition in addition to CSU.
- Medical condition that would cause additional risk or interfere with study procedures.
- Known HIV, hepatitis B or hepatitis C infection.
- Vaccination of a live vaccine within 30 days prior to Screening (Visit 1) (subjects must agree to avoid live vaccinations during the study). Inactivated vaccines are allowed such as seasonal influenza injection or authorized COVID-19 vaccine.
- History of anaphylaxis
- Prior treatment with barzolvolimab
There are additional criteria that your study doctor will review with you to confirm you are eligible for the study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: barzolvolimab 150 mg
barzolvolimab given once as a 300 mg subcutaneous injection followed by 150 mg administered every 4 weeks for 52 weeks |
Subcutaneous Administration |
|
Sperimentale: barzolvolimab 300 mg
barzolvolimab given once as a 450 mg subcutaneous injection followed by 300 mg administered every 8 weeks for 52 weeks |
Subcutaneous Administration |
|
Sperimentale: Placebo then barzolvolimab 150 mg
Placebo injection subcutaneous every 4 weeks for 24 weeks and then barzolvolimab 300 mg followed by 150 mg administered every 4 weeks for 28 weeks. |
Subcutaneous Administration Matching placebo Subcutaneous Administration |
|
Sperimentale: Placebo then barzolvolimab 300 mg
Placebo injection subcutaneous every 4 weeks for 24 weeks and then barzolvolimab 450 mg followed by 300 mg administered every 8 weeks for 28 weeks. |
Subcutaneous Administration Matching placebo Subcutaneous Administration |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean change from baseline to Week 12 of UAS7 (Urticaria Activity Score)
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Evaluate efficacy of barzolvolimab on urticaria activity as measured by urticaria activity score (UAS). The UAS7 is a simple scoring system to evaluate urticaria signs and symptoms. It is based on scoring wheals (hive severity score) and itch (itch severity score) separately on a scale of 0 (no signs/symptoms) to 3 (intense signs/symptoms) over 7 days. The final score is calculated by adding together the daily scores, which can range from 0 to 6, for 7 days. This results in a maximum total score of 42, and a minimum possible score of 0. |
From Day 1 (first dose) to Day 85 (Week 12)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean change from baseline to Week 12 of ISS7 (Itch Severity Score)
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
The ISS7 and HSS7 combined together make up the UAS7 scoring system to evaluate urticaria signs and symptoms. The ISS7 is the itch severity score for 7 days, the scores range from 0 to 21. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Mean change from baseline to Week 12 of HSS7 (Hives Severity Score)
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
The ISS7 and HSS7 combined together make up the UAS7 scoring system to evaluate urticaria signs and symptoms. The HSS7 score is the wheal/hives severity score for 7 days, the scores range from 0 to 21. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Percentage of participants with UAS7 ≤ 6 at Week 12
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Proportion of participants who achieve control of their urticaria signs and symptoms (UAS7≤6) at Week 12. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Percentage of participants with AAS7 > 0 at baseline with AAS7 = 0 at Week 12
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Proportion of participants with AAS7 > 0 at Day 1 who achieved complete control (AAS7 = 0) at Week 12 Angioedema Activity Score over 7 days [AAS7] describes the effect of angioedema on five categories with 0 being none and 3 being most severe. The final score is calculated by adding together daily scores which can range from 0-15 for 7 days. The resulting maximum score is then 105. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Mean change from baseline in UAS7 in participants refractory to omalizumab treatment at Week 12
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Evaluate efficacy of barzolvolimab on urticaria activity as measured by urticaria activity score (UAS) in participants who did not respond to or did not tolerate omalizumab. The UAS7 is a simple scoring system to evaluate urticaria signs and symptoms. It is based on scoring wheals (hive severity score) and itch (itch severity score) separately on a scale of 0 (no signs/symptoms) to 3 (intense signs/symptoms) over 7 days. The final score is calculated by adding together the daily scores, which can range from 0 to 6, for 7 days. This results in a maximum total score of 42, and a minimum possible score of 0. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Proportion of participants with UAS7 = 0 in participants refractory to omalizumab treatment at Week 12
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Proportion of participants who achieve complete absence of hives and itch (UAS7 = 0) at Week 12 in participants who did not respond to or did not tolerate omalizumab. |
From Day 1 (first dose) to Day 85 (Week 12)
|
|
Incidence of Treatment-Emergent Adverse Events
Lasso di tempo: From Day 1 (first dose) to Day 477 (Week 68)
|
Occurrence of treatment emergent adverse events and serious adverse events during the study. |
From Day 1 (first dose) to Day 477 (Week 68)
|
|
Percentage of patients with UAS7=0 at Week 12
Lasso di tempo: From Day 1 (first dose) to Day 85 (Week 12)
|
Proportion of participants who achieve complete absence of hives and itch (UAS7 = 0) at Week 12. |
From Day 1 (first dose) to Day 85 (Week 12)
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Processi patologici
- Malattia cronica
- Attributi della malattia
- Malattie del sistema immunitario
- Ipersensibilità, immediata
- Ipersensibilità
- Malattie della pelle
- Orticaria
- Malattie della pelle, vascolari
- Condizioni patologiche, segni e sintomi
- Malattie della pelle e del tessuto connettivo
- Orticaria cronica
Altri numeri di identificazione dello studio
- CDX0159-13
- 2024-513210-36-00 (Ctis)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .